![Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in HER2– Metastatic Breast Cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials - Clinical Breast Cancer Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in HER2– Metastatic Breast Cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials - Clinical Breast Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7bca94c1-b13a-4805-8a54-21b3e90caf09/gr1.jpg)
Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in HER2– Metastatic Breast Cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials - Clinical Breast Cancer
Transhepatic Arterial Chemoembolization with Oxaliplatin-eluting Microspheres (OEM-TACE) for Unresectable Hepatic Tumors
Istituti Clinici Scientifici Maugeri - Vittoria Monguzzi, geriatra dell'ICS Maugeri di Lissone (Mb) è stata vaccinata ieri contro il Covid-19 nel Vax-day organizzato dall'ASST Monza e Brianza. Come i suoi colleghi Federico
Raman spectroscopy on microcalcifications reveals peculiar differences between male and female breast cancer
![Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force☆ - ESMO Open Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force☆ - ESMO Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ac0c4c6f-590b-47b9-81aa-befff650b0cd/gr1_lrg.jpg)
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force☆ - ESMO Open
![Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places](https://www.researchgate.net/publication/360174655/figure/fig2/AS:1160708800692226@1653745951799/Kaplan-Meier-curves-of-high-and-low-risk-of-progression-patients-based-on-PFS-nomograms_Q320.jpg)
Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places
![Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places](https://www.researchgate.net/publication/360174655/figure/fig1/AS:1160708800679938@1653745951781/Nomogram-for-PFS-prediction-Each-variables-value-is-associated-with-a-score-points-bar_Q320.jpg)
Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places
Eribulin across multiple lines of chemotherapy: a retrospective study on quality of life and efficacy in metastatic breast cance
La gestione della paziente con carcinoma mammario avanzato: dalle innovazioni terapeutiche alla pratica clinica Un percorso pers
![Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places](https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg)
Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places
![Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study - ESMO Open Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study - ESMO Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2c37185c-f26d-4eb5-8b85-670b1176b60b/gr1_lrg.jpg)
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study - ESMO Open
![Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA) | SpringerLink Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-021-06474-3/MediaObjects/10549_2021_6474_Fig1_HTML.png)
Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA) | SpringerLink
![Cancers | Free Full-Text | Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy) Cancers | Free Full-Text | Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy)](https://www.mdpi.com/cancers/cancers-12-02941/article_deploy/html/images/cancers-12-02941-g001.png)